Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CV death occurred in 123 patients (7.0%) on Ozempic and 169 patients (9.6%) on placebo
DELIVER G was a retrospective pre-post study of 271 adult patients with type 2 diabetes receiving GLP-1 RA therapy who were insulin-naive prior to subsequent treatment intensification with Gla-300
The hazard-ratios [95% CI] of the composite kidney outcome with GLP-1 RAs versus basal insulin were 0.96 [0.821.11] (p = 0.566) and 0.71 [0.540.95] (p = 0.020) in the ITT and AT analyses, respectively
October 21, 2025
The expansions, covering both existing facilities and new constructions, will meet the pharmaceutical industrys most stringent quality and technical standards for short and long peptide manufacturing, including BLA requirements
US$ 23.39
US$ 29.71
US$ 24.45
US$ 25.19
US$ 20.11
US$ 24.44
US$ 27.25
